Trials / Completed
CompletedNCT05300763
Clinical Performance of Senofilcon A Investigational Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 344 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
This study is a controlled, randomized, subject-masked, 2-arm parallel, 2-week dispensing, bilateral evaluation where the study lenses are worn for a minimum of 5 days per week and 6 hours per day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | senofilcon A prototype | Test |
| DEVICE | Dailies Total 1 | Control |
Timeline
- Start date
- 2022-03-21
- Primary completion
- 2022-05-25
- Completion
- 2022-05-25
- First posted
- 2022-03-29
- Last updated
- 2023-06-22
- Results posted
- 2023-06-22
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05300763. Inclusion in this directory is not an endorsement.